Key result
Chlamydia species are detected in ~79% of atherosclerotic coronary specimens versus 4% of controls.
Why the study?
Is the presence of Chlamydia species increased in atherosclerotic coronary arteries compared to nonatherosclerotic controls?
Case-Control (n=114)
Is the presence of Chlamydia species increased in atherosclerotic coronary arteries compared to nonatherosclerotic controls?
There is a significantly higher incidence of Chlamydia species in atherosclerotic coronary arteries compared to nonatherosclerotic controls, suggesting a potential etiologic role in coronary atherosclerosis.
OBJECTIVES: The objectives of this study were to test prospectively for an association between Chlamydia and atherosclerosis by comparing the incidence of the pathogen found within atherosclerotic plaques in patients undergoing directional coronary atherectomy with a variety of control specimens and comparing the clinical features between the groups. BACKGROUND: Previous work has suggested an association between Chlamydia pneumoniae infection and coronary atherosclerosis, based on the demonstration of increased serologic titers and the detection of bacteria within atherosclerotic tissue, but this association has not yet been regarded as established. METHODS: Coronary specimens from 90 symptomatic patients undergoing coronary atherectomy were tested for the presence of Chlamydia species using direct immunofluorescence. Control specimens from 24 subjects without atherosclerosis (12 normal coronary specimens and 12 coronary specimens from cardiac transplant recipients with subsequent transplant-induced coronary disease) were also examined. RESULTS: Coronary atherectomy specimens were definitely positive in 66 (73%) and equivocally positive in 5 (6%), resulting in 79% of specimens showing evidence for the presence of Chlamydia species within the atherosclerotic tissue. In contrast, only 1 (4%) of 24 nonatherosclerotic coronary specimens showed any evidence of Chlamydia. The statistical significance of this difference is a p value < 0.001. Transmission electron microscopy was used to confirm the presence of appropriate organisms in three of five positive specimens. No clinical factors except the presence of a primary nonrestenotic lesion (odds ratio 3.0, p = 0.057) predicted the presence of Chlamydia. CONCLUSIONS: This high incidence of Chlamydia only in coronary arteries diseased by atherosclerosis suggests an etiologic role for Chlamydia infection in the development of coronary atherosclerosis that should be further studied.
No takes yet. Share an insight, caveat, or question.
Muhlestein et al. (1996) conducted a case-control in Coronary atherosclerosis (n=114). Symptomatic coronary atherosclerosis vs. No atherosclerosis (normal coronary specimens or transplant-induced coronary disease) was evaluated on Presence of Chlamydia species within coronary specimens (p=< 0.001). Chlamydia species were detected in 79% of coronary specimens from patients with symptomatic atherosclerosis compared to 4% of nonatherosclerotic control specimens (p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: